Publications dans lesquelles il/elle collabore avec Alberto Orfao (23)

2023

  1. Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations

    Frontiers in Immunology, Vol. 14

2022

  1. Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  2. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

    Frontiers in Immunology, Vol. 13

  3. Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting

    Frontiers in Medicine, Vol. 9

2021

  1. Deepening into intracellular signaling landscape through integrative spatial proteomics and transcriptomics in a lymphoma model

    Biomolecules, Vol. 11, Núm. 12

  2. Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation

    Frontiers in Immunology, Vol. 12

  3. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

2018

  1. In-depth proteomic characterization of classical and non-classical monocyte subsets

    Proteomes, Vol. 6, Núm. 1

  2. Screening phage-display antibody libraries using protein arrays

    Methods in Molecular Biology (Humana Press Inc.), pp. 365-380

2017

  1. A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells

    Oncotarget, Vol. 8, Núm. 26, pp. 42836-42846

  2. Functional proteomic insights in B-cell chronic lymphocytic leukemia

    Expert Review of Proteomics, Vol. 14, Núm. 2, pp. 137-146

2016

  1. Methods for selecting phage display antibody libraries

    Current Pharmaceutical Design, Vol. 22, Núm. 43, pp. 6490-6499

  2. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia

    Proteomics, Vol. 16, Núm. 8, pp. 1193-1203

2015

  1. Evaluation Strategies of Nanomaterials Toxicity

    NANOMATERIALS - TOXICITY AND RISK ASSESSMENT (INTECH EUROPE), pp. 23-37

  2. High-throughgput phage-display screening in array format

    Enzyme and Microbial Technology, Vol. 79-80, pp. 34-41

  3. Integration of proteomics and transcriptomics data sets for the analysis of a lymphoma B-cell line in the context of the chromosome-centric human proteome project

    Journal of Proteome Research, Vol. 14, Núm. 9, pp. 3530-3540

2014

  1. Emerging Nanotechniques in Proteomics

    Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 137-157

  2. Protein Microarrays: Overview, Applications and Challenges

    GENOMICS AND PROTEOMICS FOR CLINICAL DISCOVERY AND DEVELOPMENT (SPRINGER), pp. 147-173

  3. Serum Profiling by Targeted Proteomics for Biomarker Discovery

    PROTEOMICS: TARGETED TECHNOLOGY, INNOVATIONS AND APPLICATIONS (CAISTER ACADEMIC PRESS), pp. 19-33

  4. Targeted Proteomics for Chronic Lymphocytic Leukaemia

    PROTEOMICS: TARGETED TECHNOLOGY, INNOVATIONS AND APPLICATIONS (CAISTER ACADEMIC PRESS), pp. 57-69